hers - Search News

News

Hims & Hers CEO No Longer A Billionaire

Hims & Hers CEO No Longer A Billionaire After Novo Nordisk Deal Collapses

The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more than $400 million on Monday.

Reuters on MSN · 4h

Novo, Hims & Hers engage in war of words after Wegovy deal falls apart

Novo Nordisk ended a short-lived agreement to sell its Wegovy weight-loss drug through Hims & Hers Health on Monday, sending shares of the U.S. telehealth company plunging more than 30%.

Financial Times · 4h

Novo Nordisk ends Hims & Hers tie-up over copycat Wegovy drugs

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments

6hon MSN

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

3hon MSN

Why Hims & Hers Health Stock Is Crashing Today

The loss of its ability to sell Wegovy is a significant hit to Hims & Hers' business. The massive drop today in its stock ...

1hon MSN

These Stocks Moved the Most Today: Tesla, Hims & Hers, Wolfspeed, Super Micro, Fiserv, Northrop, Northern Trust, and More

Tesla shares rise sharply after the electric-vehicle company launched its highly anticipated robo-taxi service in Austin, ...

9h

Hims & Hers Health Stock Is Tumbling Monday: What's Happening?

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Monday after Novo Nordisk A/S (NYSE:NVO) terminated its ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results